Neurobiological Technologies, Inc.
NTII · OTC
9/30/2009 | 6/30/2009 | 3/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -63% | 440.4% | -13.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 85.7% | 90.6% | -8.6% | -230.9% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 89.7% | 86.9% | -14.3% | -224.5% |
| EPS Diluted | 0.2 | 0.525 | -0.02 | -0.29 |
| % Growth | -61.9% | 2,727.3% | 93.1% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |